• 1
    Krantz M. J., Mehler P. S. Treating opioid dependence. Growing implications for primary care. Arch Intern Med 2004; 164: 27788.
  • 2
    Ball J. C., Ross A, editors. The Effectiveness of Methadone Maintenance Treatment. New York: Springer; 1991.
  • 3
    Farrell M., Ward J., Mattick R., Hall W., Stimson G. V., Des Jarlais D. et al. Methadone maintenance treatment in opiate dependence: a review. BMJ 1994; 309: 9971001.
  • 4
    Marsch L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998; 93: 51532.
  • 5
    Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend 2008; 94: 1517.
  • 6
    Mattick R. P., Hall W. Are detoxification programmes effective? Lancet 1996; 347: 97100.
  • 7
    O'Brien C. P. Opiate detoxification: what are the goals? Addiction 2005; 100: 1035.
  • 8
    Gowing L., Ali R. The place of detoxification in treatment of opioid dependence. Curr Opin Psychiatry 2006; 19: 26670.
  • 9
    Gossop M., Johns A., Green L. Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. BMJ (Clin Res Ed) 1986; 12: 1034.
  • 10
    Backmund M., Meyer K., Eichenlaub D., Schütz C. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug Alcohol Depend 2001; 64: 17380.
  • 11
    Haas S., Busch M., Horvath I., Türscherl E., Weigl M., Wirl C. Report on the Drug Situation 2008. GÖG/ÖBIG report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Vienna: Gesundheit Österreich GmbH; 2008.
  • 12
    Fischer G., Jagsch R., Eder H., Gombas W., Etzersdorfer P., Schmidl-Mohl K. et al. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999; 94: 23139.
  • 13
    Kraigher D., Ortner R., Eder H., Schindler S., Fischer G. Slow-release morphine hydrochloride for maintenance therapy of opioid dependence. Wien Klin Wochenschr 2002; 114: 90410.
  • 14
    Mitchell T. B., White J. M., Somogyi A. A., Bochner F. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 2004; 99: 9405.
  • 15
    Eder H., Jagsch R., Kraigher D., Primorac A., Ebner N., Fischer G. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005; 100: 11019.
  • 16
    Vasilev G., Alexieva D., Pavlova R. Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: a 6-month open noncomparative study. Eur Addict Res 2006; 12: 5360.
  • 17
    Kastelic A., Dubajic G., Strbad E. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Addiction 2008; 103: 183746.
  • 18
    Hagen N. A., Thirlwell M., Eisenhoffer J., Quigley P., Harsanyi Z., Drake A. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL®) in cancer pain. J Pain Symptom Manage 2005; 29: 8090.
  • 19
    Gsellhofer B., Küfner H., Vogt M., Weiler D., editors. European Addiction Severity Index: EuropASI (German version) Manual für Training und Durchführung. Baltmannsweiler: Schneider-Verlag Hohengehren; 1999.
  • 20
    Heppekausen K., Rist F., Scherbaum N. A. German version of the Short Opiate Withdrawal Scale (SOWS-G). In: Glöckner-RistA., RistF., KüfnerH., editors. Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES), version 3.00. Mannheim: Zentren für Umfragen, Methoden und Analysen; 2003, (accessed March 2009).
  • 21
    Franke G. H., editor. SCL- 90-R: Symptom-Checklist from L. R. Derogatis (German version), 2nd edn. Göttingen: Beltz Test GmbH; 2002.
  • 22
    Nutt D., Allgulander C., Lecrubier Y., Wittchen, P. U. Establishing non-inferiority in treatment trials in psychiatry—guidelines from an Expert Consensus Meeting. J Psychopharmacol 2008; 22: 40916.
  • 23
    Gossop M., Bradley B., Phillips G. T. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addict Behav 1987; 12: 16.
  • 24
    Strang J., Gossop M. Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts. Addict Behav 1990; 15: 5417.
  • 25
    Kleber H. D. Opioids: detoxification. In: GalanterM., KleberH. D., editors. Textbook of Substance Abuse Treatment, 2nd edn. Washington, DC: American Psychiatric Press; 1999, p. 25169.
  • 26
    San L., Camí J., Fernández T., Ollé J. M., Peri J. M., Torrens M. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict 1992; 87: 5562.
  • 27
    Dawe S., Griffiths P., Gossop M., Strang J. Should opiate addicts be involved in controlling their own detoxification? A comparison of fixed versus negotiable schedules. Br J Addict 1991; 86: 97782.
  • 28
    Stitzer M., Bigelow G., Liebson I. Comparison of three out-patient methadone detoxification procedures. NIDA Res Monogr 1982; 41: 23945.
  • 29
    Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 1997; 21: 91104.
  • 30
    Eklund C., Hiltunen A. J., Melin L., Borg S. Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone. Subst Use Misuse 1997; 32: 77992.
  • 31
    Dutra L., Stathopoulou G., Basden S. L., Leyro T. M., Powers M. B., Otto M. W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 17987.
  • 32
    Van Den Brink W., Haasen C. Evidence-based treatment of opioid-dependent patients. Can J Psychiatry 2006; 51: 63546.